Skip to content

A study on the relationship between sleep problems and blood lipid levels during pregnancy and their effects on pregnancy outcomes

Correlation Between Sleep Disorders and Abnormal Lipid Metabolism During Pregnancy and Their Impact on Pregnancy Outcomes

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500114327
Enrollment
Unknown
Registered
2025-12-10
Start date
2025-12-12
Completion date
Unknown
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abnormal lipid metabolism during pregnancy and pregnancy-related sleep disorders

Interventions

Normal sleep quality group:NA
Poor sleep quality group:NA

Sponsors

Shanghai General Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Singleton pregnancy, with gestational age of 10–14 weeks at enrollment (confirmed by ultrasound or last menstrual period); 2. Age between 18 and 45 years; 3. Planning to receive prenatal care and deliver at the study center, and able to complete follow-up visits; 4. Able to accept and cooperate with sleep assessments (PSQI questionnaire); 5. Provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe systemic diseases, including active hepatic or renal insufficiency, heart failure, malignant tumors, systemic lupus erythematosus, or other major systemic disorders; 2. Night-shift workers whose circadian rhythm assessment would be significantly affected; 3. Long-term use of medications that affect sleep and cannot be discontinued in the short term (e.g., benzodiazepines, prescription hypnotics, antipsychotic medications); 4. Individuals with a family history of familial hyperlipidemia.

Design outcomes

Primary

MeasureTime frame
Maternal lipid profile during pregnancy (TC, TG, HDL-C, LDL-C);

Secondary

MeasureTime frame
Pregnancy outcomes (preterm birth, fetal growth restriction, low birth weight, etc.);

Countries

China

Contacts

Public ContactLu Cong

Shanghai General Hospital

jiegan@sina.com+86 21 37798531

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026